Eli Lilly and Company (LLY)
Pretax margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 6,554,600 | 6,806,400 | 6,155,500 | 7,229,900 | 8,946,400 |
| Revenue | US$ in thousands | 34,124,100 | 28,541,400 | 28,318,400 | 24,539,800 | 22,319,500 |
| Pretax margin | 19.21% | 23.85% | 21.74% | 29.46% | 40.08% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $6,554,600K ÷ $34,124,100K
= 19.21%
The pretax margin of Lilly(Eli) & Co has exhibited fluctuations over the past five years. In 2020, the company achieved its highest pretax margin of 29.46%, indicating efficient management of expenses relative to its revenue before accounting for taxes. However, in 2023, the pretax margin decreased to 19.21%, suggesting a decrease in profitability compared to the previous year.
It is essential for stakeholders to closely monitor the factors affecting the pretax margin, such as changes in revenue, cost management strategies, and tax obligations, to assess the company's overall financial performance and sustainability. Further analysis and investigation into the drivers behind these fluctuations are recommended to determine the underlying reasons for the variability in the pretax margin of Lilly(Eli) & Co.
Peer comparison
Dec 31, 2023